Patent · US Expired

Piperazine substituted pyrimidine derivatives and physiologically tolerated salts thereof

US5138058A · kind A · utility

41Cited by
9References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 20, 1990
Grant dateAug 11, 1992
Priority date
Expiry dateFeb 20, 2010

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pyrimidine derivatives of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 have the indicated meanings, the salts thereof, and a process for the preparation thereof are described. Because of their sorbitol-accumulating activity, they are suitable as a tool in a pharmacological screening model for aldose reductase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.